ANNX
Price
$2.37
Change
+$0.01 (+0.42%)
Updated
Aug 11, 11:41 AM (EDT)
Capitalization
258.93M
7 days until earnings call
FULC
Price
$6.44
Change
-$0.05 (-0.77%)
Updated
Aug 11, 02:44 PM (EDT)
Capitalization
351.05M
93 days until earnings call
Interact to see
Advertisement

ANNX vs FULC

Header iconANNX vs FULC Comparison
Open Charts ANNX vs FULCBanner chart's image
Annexon
Price$2.37
Change+$0.01 (+0.42%)
Volume$100
Capitalization258.93M
Fulcrum Therapeutics
Price$6.44
Change-$0.05 (-0.77%)
Volume$300
Capitalization351.05M
ANNX vs FULC Comparison Chart in %
Loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANNX vs. FULC commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a Hold and FULC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (ANNX: $2.36 vs. FULC: $6.49)
Brand notoriety: ANNX and FULC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 73% vs. FULC: 58%
Market capitalization -- ANNX: $258.93M vs. FULC: $351.05M
ANNX [@Biotechnology] is valued at $258.93M. FULC’s [@Biotechnology] market capitalization is $351.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 1 FA rating(s) are green whileFULC’s FA Score has 1 green FA rating(s).

  • ANNX’s FA Score: 1 green, 4 red.
  • FULC’s FA Score: 1 green, 4 red.
According to our system of comparison, FULC is a better buy in the long-term than ANNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 3 TA indicator(s) are bullish while FULC’s TA Score has 4 bullish TA indicator(s).

  • ANNX’s TA Score: 3 bullish, 6 bearish.
  • FULC’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, FULC is a better buy in the short-term than ANNX.

Price Growth

ANNX (@Biotechnology) experienced а -3.67% price change this week, while FULC (@Biotechnology) price change was -4.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.49%. For the same industry, the average monthly price growth was +31.98%, and the average quarterly price growth was +19.31%.

Reported Earning Dates

ANNX is expected to report earnings on Aug 18, 2025.

FULC is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+22.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FULC($351M) has a higher market cap than ANNX($259M). FULC YTD gains are higher at: 38.085 vs. ANNX (-53.996). FULC has higher annual earnings (EBITDA): -81.28M vs. ANNX (-180.76M). ANNX has more cash in the bank: 264M vs. FULC (214M). FULC has less debt than ANNX: FULC (7.57M) vs ANNX (28.3M). ANNX (0) and FULC (0) have equivalent revenues.
ANNXFULCANNX / FULC
Capitalization259M351M74%
EBITDA-180.76M-81.28M222%
Gain YTD-53.99638.085-142%
P/E RatioN/AN/A-
Revenue00-
Total Cash264M214M123%
Total Debt28.3M7.57M374%
FUNDAMENTALS RATINGS
FULC: Fundamental Ratings
FULC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANNXFULC
RSI
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 19 days ago
84%
Bullish Trend 26 days ago
88%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
73%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIRDF21.220.14
+0.66%
Bird Construction Inc.
ENDI16.00N/A
N/A
ENDI Corp.
BCHMY7.28N/A
N/A
Bachem Holding AG
NPSNY63.08-0.39
-0.61%
Naspers Ltd.
PURE0.08-0.01
-7.13%
PURE Bioscience

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with OCUL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
-0.42%
OCUL - ANNX
48%
Loosely correlated
-0.73%
IDYA - ANNX
48%
Loosely correlated
+3.08%
NRIX - ANNX
46%
Loosely correlated
-2.28%
ERAS - ANNX
45%
Loosely correlated
-4.11%
ZYME - ANNX
44%
Loosely correlated
-1.15%
More

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ANNX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ANNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
-4.70%
ANNX - FULC
40%
Loosely correlated
-0.42%
VRDN - FULC
40%
Loosely correlated
-0.73%
RARE - FULC
39%
Loosely correlated
-1.04%
MRNA - FULC
38%
Loosely correlated
-1.84%
BMRN - FULC
38%
Loosely correlated
N/A
More